Article
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
2020-06-05
Abstract excerpt
<h4>Aims</h4> Severity of outcome in COVID-19 is disproportionately higher among the obese, males, smokers, those suffering from hypertension, kidney disease, coronary heart disease (CHD) and/or type 2 diabetes (T2D). We examined if serum levels of ACE2, the cellular entry point for the coronavirus SARS-CoV-2, were altered in these high-risk groups. <h4>Methods</h4> Associations of serum ACE2 levels to hypertensio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5105d5e-212f-5963-a109-2590bbce3abf
- DOI
- 10.1101/2020.06.04.20122044
